It’s been a pleasure and an exciting few days to be part of HVC Kyoto 2026 and to present neubond. It was amazing to meet potential partners and stakeholders in Japan, as well as so many inspiring entrepreneurs in the biotech / biomedical fields 🔬🩺 A huge thank you to JETRO - Collaborate & Invest Japan for inviting us to this incredible event. We are excited about the opportunities ahead!
HVC KYOTO 2026 Demo Day was held on July 14. HVC KYOTO is one of Japan’s largest open innovation platforms, connecting startups from Japan and overseas with corporations worldwide and investors in the healthcare sector, including drug discovery, biotechnology, regenerative medicine, digital health, and medical devices. At Demo Day, 12 finalist startups selected from this year’s cohort took the stage, along with three BioTech and MedTech startups from the UK, delivering their pitches in English. The event also featured active matchmaking sessions between startups and corporations, VCs, and other organizations seeking business partnerships, joint research opportunities, and investment opportunities. Awards were also presented during the event, with Decelink Bio Co., Ltd. receiving the JETRO Award. Congratulations to all the award winners. From Kyoto to the world. #HVCKYOTO #HealthcareInnovation #Startup #OpenInnovation #DigitalHealth #MedTech #Biotech #Kyoto #Innovation #HealthcareStartup
-
-
-
-
-
+3